Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular System in Obesity: Effect of Treatment
NCT00000506Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- May 1983
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of fenfluramine and phentermine in obesity (3 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Weight Loss at 4 years. Started May 1983; status: completed.
02
Drugs
fenfluraminephentermine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00000506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000506.